Navigation Links
Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia
Date:9/22/2008

Therefore, key stakeholders such as hospital infectious disease specialists and clinicians developing an institution's guidelines typically have broad influence on prescribing well beyond their own patients.

AMR and Decision Resources' new Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with Decision Resources' disease area knowledge, primary research and extensive understanding of emerging therapies and forecasts. These reports examine the reasons behind physicians' product preferences, factors driving hospital antibiotic prescribing patterns and receptivity to emerging antibiotics.

2008 Hospital Anti-Infective Insight Series reports include:

-- Hospital Anti-Infective Insight Series: Nosocomial Pneumonia

-- Hospital Anti-infective Insight Series: Skin & Soft Tissue Infections

-- Hospital Anti-Infective Insight Series: U.S. Antibiotic Usage Patterns

and Drivers in the ICU Setting

About AMR

AMR (http://www.AMR-data.com) serves the market intelligence needs of the pharmaceutical and diagnostic imaging industries. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits.

About Decision Resources

Decision Resources (http://www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of
'/>"/>

SOURCE Arlington Medical Resources; Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
4. Physicians Will Benefit from Medical Software Advice Website
5. Physicians Reconsider Implications of Enhance Trial
6. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
7. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
8. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
9. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
10. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
11. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) ... of schizophrenia and manic or mixed episodes associated with ... ,, The updated Zyprexa label states that clinicians ... gain and hyperlipidemia in adolescents compared to adults and ...
(Date:12/4/2009)... Pharmacy announced today that it received accreditation by the ... pharmacy services. For nearly 15 years, Amber Pharmacy has ... the unique needs of specialized conditions. Amber Pharmacy is ... programs. They work with over 170 transplant programs and ...
(Date:12/4/2009)... STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, ... systems and service programs for hospitals and healthcare ... The Joint Commission,s Accreditation for Ambulatory Health Care, ... quality and safety in patient care. Shared Imaging ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Women 26apos 3Bs Hair Loss Treatment Results Captured on Video to Inspire Others 61992 1Women 26apos 3Bs Hair Loss Treatment Results Captured on Video to Inspire Others 61992 2Women 26apos 3Bs Hair Loss Treatment Results Captured on Video to Inspire Others 61992 3Colombian National Pleads Guilty to Role in Defrauding the Export Import Bank of the United States of More Than 241 Million 6491 1Colombian National Pleads Guilty to Role in Defrauding the Export Import Bank of the United States of More Than 241 Million 6491 2Pennsylvania Agriculture Department Encourages Proper Food Handling Offers Safety Tips for Thanksgiving 61989 1Pennsylvania Agriculture Department Encourages Proper Food Handling Offers Safety Tips for Thanksgiving 61989 2
... MedNet Solutions, a global life sciences technology ... today announced the company,s leading role and active ... the 13th Annual EDC & Beyond conference, to ... 30 in Orlando, Florida.The conference organizers have invited ...
... LINTHICUM, Md., April 27 Several new studies presented ... Meeting suggest that the use of statins--commonly prescribed to ... or lower urinary tract symptoms (LUTS). Several key research ... special panel for the media on Monday, April ...
Other Medicine Technology:MedNet Solutions to Share Industry Expertise at the 13th Annual EDC & Beyond Conference in Orlando, FL 2New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health 2
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Onyx Pharmaceuticals, ... safety data from the pivotal Phase 2b 003-A1 ... carfilzomib is well-tolerated in heavily pre-treated relapsed and ... today at the ASH/ASCO Joint Symposium at the ... Hematology (ASH) in New Orleans. Enrollment in this ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... myeloproliferative disorders are serious and often deadly blood ... Meeting of the American Society of Hematology introduces ... for patients suffering from acute promyelocytic leukemia, chronic ... that are based on a better understanding of ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... positive results, ROSEMONT, Ill., Nov. 3 ... condition known as clubfoot,have similarly high levels of ... November 2008 issue of The Journal of Bone ... strategies use different,approaches, each brings positive outcomes for ...
... EL SEGUNDO, Calif., Nov. 3 The ... only national organization creating hope in a,comprehensive ... and,advocacy for a cure, launches Raise Your ... Pancreatic,Cancer Awareness Month. Raise Your Voice and ...
... The Zon hearing aid, designed by,Stuart Karten Design for ... presented by the Smithsonian,s Cooper-Hewitt, National Design,Museum., At ... New,York on Oct. 23, Padma Lakshmi, host of Bravo,s ... to Stuart Karten., "In developing Zon, we sought ...
... Group, the,premier strategic interactive marketing agency serving the ... Deloitte,s prestigious Fast,50 Program for Greater Philadelphia - ... and life sciences companies in the,area by Deloitte ... Rankings are based on the percentage revenue growth ...
... "When my father was formally,diagnosed with Alzheimer,s in ... article I could get my hands on," writes Michele ... (published by,AuthorHouse -- http://www.authorhouse.com ). "Educate, educate, educate ... that once I knew the facts, I,could get the ...
... trend, researchers say , , MONDAY, Nov. 3 (HealthDay ... United States is dramatically increasing as more kids ... hyperactivity disorder (ADHD), researchers report. , Increased prescribing ... obesity among children and the health consequences of ...
Other Medicine News:Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 2Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 3Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 2Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 3Health News:Stuart Karten Design's Zon Hearing Aid Wins 2008 Cooper-Hewitt People's Design Award 2Health News:Stuart Karten Design's Zon Hearing Aid Wins 2008 Cooper-Hewitt People's Design Award 3Health News:Cadient Group Ranked 34th in Deloitte's Fast 50 Program for Greater Philadelphia 2Health News:'A Conversation About Alzheimer's': Woman Shares Story of Love, Hope, Loss and Survival in New Book About Alzheimer's Disease 2Health News:Use of Kids' Meds on the Increase 2Health News:Use of Kids' Meds on the Increase 3
... InstaCheck® multi-drug test device provides ... easily. Negative results can be ... 3 minutes; positive results require ... one-time urine sample application will ...
... are available in 14 configurations including the ... Microgenics Antibody Technology, the SureStep™ MDMA (Ecstasy) ... immunoassay targeted to detect MDMA that has ... but no cross-reactivity to any isomer of ...
... At Home Drug Test is the first rapid ... home use. The kit includes a rapid drug-screening ... instructions, a handbook with frequently asked questions and ... to the laboratory if the screening device indicates ...
... Our most popular onsite test! QuickScreen™ ... the urine sample, and your choice of ... QuickScreen™ multi-panels offer total flexibility for your ... into the specimen and the built-in timer ...
Medicine Products: